BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:20 PM
Feb 20, 2007
 |  BC Extra  |  Company News

FDA accepts telavancin NDA

FDA accepted for filing an NDA from Theravance (THRX) for telavancin to treat complicated skin and skin structure infections (cSSSIs)...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >